Benzinga | Nov 15, 2021 06:20PM EST

Eton Pharmaceuticals Q3 EPS $(0.24) Misses $(0.13) Estimate, Sales $775.00K Miss $3.04M Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.13) by 84.62 percent. This is a 22.58 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $775.00 thousand which missed the analyst consensus estimate of $3.04 million by 74.51 percent. This is a 581.37 percent increase over sales of $(161.00 thousand) the same period last year.